key: cord-0919109-vn50j5sw authors: Mertoglu, Cuma; Huyut, Mehmet Tahir; Olmez, Hasan; Tosun, Mustafa; Kantarci, Mecit; Coban, Taha Abdulkadir title: COVID-19 is more dangerous for older people and its severity is increasing: a case-control study date: 2021-10-19 journal: Med Gas Res DOI: 10.4103/2045-9912.325992 sha: 54df32baf316c26b0b4a63f3bf2edac8432d8179 doc_id: 919109 cord_uid: vn50j5sw Coronavirus disease 2019 (COVID-19) triggers important changes in routine blood tests. In this retrospective case-control study, biochemical, hematological and inflammatory biomarkers between March 10, 2020, and November 30, 2020 from 3969 COVID-19 patients (3746 in the non-intensive care unit (non-ICU) group and 223 in the ICU group) were analyzed by dividing into three groups as spring, summer and autumn. In the non-ICU group, lymphocyte to monocyte ratio was lower in autumn than the other two seasons and neutrophil to lymphocyte ratio was higher in autumn than the other two seasons. Also, monocyte and platelet were higher in spring than autumn; and eosinophil, hematocrit, hemoglobin, lymphocyte, and red blood cells decreased from spring to autumn. In the non-ICU group, alanine aminotransferase and gamma-glutamyltransferase gradually increased from spring to autumn, while albumin, alkaline phosphatase, calcium, total bilirubin and total protein gradually decreased. Additionally, C-reactive protein was higher in autumn than the other seasons, erythrocyte sedimentation rate was higher in autumn than summer. The changes in routine blood biomarkers in COVID-19 varied from the emergence of the disease until now. Also, the timely changes of blood biomarkers were mostly more negative, indicating that the disease progresses severely. The study was approved by the Erzincan Binali Yildirim University Non-interventional Clinical Trials Ethic Committee (approval No. 86041) on June 21, 2021. grouped as summer, and the results between September 1, 2020 and November 30, 2020 were grouped as autumn. The test results obtained from the first measurements of the patients recorded in the system were evaluated in this study. The whole blood count was measured with Sysmex XN-1000 instrument (Sysmex Corporation, Kobe, Japan) autoanalyzer, and biochemical tests were made with the spectrophotometric method from serum in the Olympus AU2700 Plus Chemistry Analyzer (Beckman Coulter, Tokyo, Japan) autoanalyzer. Serum ferritin was measured by chemiluminescence method in the autoanalyzer (Centaur XP, Siemens Healthcare, Germany). Prothrombin time, activated partial prothrombin time and fibrinogen on plasma was measured with a fully automated photo-optical coagulation device Ceveron-Alpha (Diapharma Group Inc., West Chester, Canada). C-reactive protein (CRP) was measured on serum by nephelometric method on BN™ II device (Siemens, Munich, Germany). Procalcitonin, D-dimer, and Troponin I were measured from the whole blood with AQT90 flex Radiometer ® (Bronshoj, Denmark) device. The erythrocyte sedimentation rate (ESR) was analyzed on whole blood using TEST 1 BCL (Alifax, Padova, Italy). Neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR) and platelet to lymphocyte ratio (PLR) calculated as neutrophil/lymphocyte, lymphocyte/monocyte and platelet/lymphocyte, respectively. Derived NLR ratio was calculated neutrophil count divided by the result of white blood cell (WBC) count minus neutrophil count. Lymphocyte to CRP ratio (LCR), a systemic immune-inflammation index, was calculated using the following formula: platelet × neutrophil / lymphocyte. The atherogenic index of plasma is the logarithmically transformed ratio of triglycerides and high-density lipoprotein cholesterol. The values of the group with increased biomarker levels were defined as the upper threshold of the reference range and the values of the group with decreased biomarker levels were defined as the lower threshold of the reference range. Thus, how much they changed was determined. The one-way analysis of variance was used when the data were normally distributed in the three groups; otherwise, the Kruskal-Wallis test was carried out. An independent t-test or Mann-Whitney U test was used to evaluate the continuous variables between groups. Using the chi-square test, proportions for categorical variables were compared. All statistical analyses were conducted by using SPSS software (version 20.0, IBM, Armonk, NY, USA). Statistical significance could be shown as the P-values < 0.05. In the non-ICU group, the ratio of men to women was higher in spring, while the ratio of women to men was higher in summer and autumn. The ratio of men was always higher in the ICU group. The mean age in the non-ICU group gradually increased from spring to autumn, which was similar in the ICU group. In the non-ICU group, basophil count was higher in spring than other two seasons, mean corpuscular hemoglobin value was only higher in spring than autumn, and mean corpuscular hemoglobin concentration (MCHC), neutrophil, platelet distribution width and red cell distribution width (RDW) values were higher in autumn than spring and higher in spring than summer. Additionally, mean corpuscular volume, platelet large cell ratio and LMR values were lower in autumn than other two seasons, monocyte, platelet and WBC (in women) were higher in spring than autumn and higher in autumn than summer, while mean platelet volume, NLR and dNLR values were higher in autumn than the other seasons, and PCT and WBC (in men) were lower in summer than the other seasons. Moreover, PLR value gradually increased from spring to autumn while eosinophil, hematocrit, hemoglobin, lymphocyte and red blood cells (RBC) values gradually decreased (Additional Table 1 ). In the ICU group, MCHC was higher in autumn than in other seasons, monocyte was higher in spring than autumn while neutrophil, WBC (in women), NLR, dNLR and PLR were lower in summer than autumn. Age, mean corpuscular volume, neutrophil, plateletcrit, platelet distribution width, RDW, WBC, platelet large cell ratio, NLR, derived NLR ratio and PLR values were higher and eosinophil, hematocrit, hemoglobin, lymphocyte, MCHC, monocyte, RBC, WBC and LMR were lower in the ICU group compared with the non-ICU group (Additional Table 2 ). In the non-ICU group, alanine aminotransferase (ALT) and gamma-glutamyltransferase (GGT) values gradually increased from spring to autumn, while albumin, alkaline phosphatase (ALP), calcium, total bilirubin, total protein, and estimated glomerular filtration rate (eGFR) gradually decreased. Additionally, aspartate aminotransferase (AST) was lower in spring than the other seasons and HDL was higher in spring than the other seasons, while AST/ALT, direct bilirubin and chlorine were lower in autumn than the other seasons. Moreover, glucose, creatinine (only in men), urea and uric acid were higher in autumn than the other seasons, and lactate dehydrogenase (LDH) was higher in summer than the other seasons, while creatine kinase myocardial band, creatinine (only in women) and lipase were lower in summer than autumn and cholesterol were higher in spring than autumn. Also, sodium level was higher in summer than autumn and atherogenic index of plasma was higher in summer than spring. In the ICU group, ALT, GGT, and creatinine (only in men) increased in summer than autumn, and AST, glucose and urea were higher in autumn than the other seasons, while calcium and eGFR were lower in autumn than the other seasons, and albumin and ALP were higher in spring than the other seasons. Additionally, LDH was higher in autumn than spring and the total protein value was lower in autumn than spring (Additional Table 3) . ALT, AST, AST/ALT, ALP, creatine kinase myocardial band, direct bilirubin, GGT, glucose, creatinine, creatine kinase, LDH, magnesium, sodium, total bilirubin, and urea were higher, while albumin, iron, calcium, total protein and eGFR were lower in the ICU group compared with the non-ICU group (Additional Table 4 ). In the non-ICU group, CRP was higher in autumn than the other seasons and ferritin (only in men) gradually increased from spring to autumn, while ferritin (in women) was lower in spring than the other seasons. Additionally, procalcitonin was higher in summer than autumn, and ESR was higher in autumn than summer, while activated partial prothrombin time was higher in summer than spring as well as higher in spring than autumn. Moreover, LCR and systemic immune-inflammation index were lower in autumn than the other seasons. In the ICU group, ferritin gradually increased from spring to autumn, while procalcitonin and systemic immune-inflammation index were higher in summer than autumn and ESR was higher in autumn than spring (Additional Table 5 ). CRP, D-dimer, ferritin, fibrinogen, international normalized ratio, prothrombin time, procalcitonin, ESR, and troponin were higher and LCR was lower in the ICU group compared with the non-ICU group (Additional Table 6 ). While COVID-19 continues to rapidly spread in the world, the disease and mortality ratios are increasing. Unfortunately, the epidemic has not been prevented as an effective treatment for the disease has yet to be found. 1 The vaccination has begun but it is too soon to see its effect. On the other hand, important mutations have been detected in the structure of the virus while the disease continues to spread. 6,7 Therefore, it is possible that COVID-19 will be in our lives for a long time. It is essential to explain this disease with all its aspects and to reveal the differences that may develop in time. In this regard, this study is important as it shows the real-time changes in routine blood biomarkers in COVID-19. Also, these changes are important for the diagnosis of the disease but the fact that the test results changed negatively indicates that the severity of the disease increased over time. This study showed that aged patients and male individuals are more likely to be hospitalized in the intensive care unit. It is known that advanced age is a bad prognostic indicator. 13 The increase in mean platelet volume, NLR, dNLR and decreased eosinophil, hematocrit, hemoglobin, lymphocyte, and RBC values indicates that the disease progresses more severely in autumn, the third period of the disease, than the early period. NLR is also an independent risk factor for mortality. 14 These results might be effective in conditions such as the increased possibility of infection of the elderly and people with chronic diseases. Increased glucose, creatinine, urea, uric acid, ALT, AST, GGT and decreased albumin, ALP, calcium, total bilirubin, total protein and eGFR in autumn show that organ damage such as pancreas, kidney and live damage is more serious in these patients. Additionally, the mutations in the virus structure or changes in the clinical characteristics of the disease might have caused this result. As CRP, ferritin, and ESR were increased while LCR was decreased in autumn, the patients might produce a more powerful inflammatory response in this last period. Previous studies reported that increased CRP, ESR, LDH and decreased albumin, eosinophil, and lymphocyte are the most important laboratory findings of the disease. 9, 10, 12 In the ICU group, mean corpuscular volume, neutrophil, plateletcrit, platelet distribution width, RDW, WBC, platelet large cell ratio, NLR, derived NLR ratio and PLR were increased, while eosinophil, hematocrit, hemoglobin, lymphocyte, MCHC, monocyte, RBC and LMR were lowered, which indicates that the immune response is defective in this group, i.e., lymphocytic and erythrocyte series in the bone marrow might have been suppressed and there might be platelet and erythrocyte deformities. Lymphopenia is the most important laboratory findings that show defective immune response and risk of hospitalization in the intensive care unit in COVID- 19. 9 Neutrophil might be related to hyperinflammation and cytokine storm or superimposed bacterial infection. 15 NLR shows the severity of inflammation and it is a powerful predictive and prognostic indicator. 8, 16 Also, the PLR value is asserted to be correlated with the severity of cytokine storm. 17 It was asserted that eosinopenia can be used in diagnosis in combination with lymphopenia. 18 Additionally, changes in the RBC parameters are related to distorted erythropoiesis. 8 High RDW is reported to be related to high mortality. 19 Moreover, more pathologies of the muscle, liver, heart, pancreas, lung and kidney were indicated in the ICU group, in which ALT, AST, AST/ALT, ALP, creatine kinase myocardial band, direct bilirubin, GGT, glucose, creatinine, creatine kinase, LDH, magnesium, sodium, total bilirubin, urea and troponin values were increased while albumin, iron, calcium, total protein and eGFR were decreased. This multi-organ involvement in COVID-19 was associated with the widespread distribution of angiotensin-converting enzyme receptors in the body. 20 High creatinine, AST, LDH, troponin, CRP, ferritin, procalcitonin, D-dimer, and fibrinogen values were reported to be the indicator of clinical deterioration and mortality in these patients. 21, 22 It is asserted that live function tests such as ALT, AST, GGT, ALP and bilirubin often increase in COVID-19 but they do not require treatment and the underlying reasons for these increased values are hyper inflammation and thrombotic microangiopathy. 23 The ratio of AST/ALT (De Ritis ratio) was found to be an important indicator especially in women. 24 It was reported that fasting hyperglycemia increases mortality as well as the development of complications. 25 It was stated that sodium, potassium and calcium are low in severe COVID-19 patients; thus, electrolytes should be monitored. 26 The reason for high sodium in the ICU group in the present study might have been iatrogenic. Additionally, increased CRP, ferritin, procalcitonin, ESR and decreased LCR values in the ICU group show that this group had a more powerful inflammatory response. CRP is a sensitive indicator of inflammation and tissue damage and it increases in most COVID-19 patients. 27, 28 Previous study reported that high CRP and LDH and lymphopenia may show the necessity to transfer the patient to intensive care. 10 It is asserted that low LCR is an indicator of high mortality and the need for mechanical ventilation. 29 A high level of procalcitonin might be due to secondary bacterial infection. 11 Increased d-Dimer and fibrinogen are the indicators of intravascular blood clot coagulation and high prothrombin time and international normalized ratio values. Therefore, these patients should be monitored in terms of the development of disseminated intravascular coagulopathy and acute respiratory distress. 11, 20, 30 Another new information provided by this study is that the ratio of the changes in routine blood biomarkers was revealed clearly. Accordingly, the increases in these tests were mostly lower than twice while decreases were lower than half (bigger than 0.5 times). Thus, even small changes in the laboratory tests of these patients must be considered. The limitations of this study are that it was designed retrospectively and single-center and that comorbidities and medications received were not included in the study. In conclusion, this study showed that the changes in routine laboratory tests in COVID-19 vary in the period from the emergence of the disease until now. There were increases in some tests, decreases in some and similarities in some during this period. Thus, the real-time changes in the routine laboratory tests in COVID-19 should be checked with new studies. Also, the real-time changes in the routine laboratory tests were mostly negative in this study, indicating that the disease progresses compared with the period when it first emerged. World Health Organization. WHO coronavirus (COVID-19) dashboard Influence of meteorological factors on the CO-VID-19 transmission with season and geographic location A close look at the biology of SARS-CoV-2, and the potential influence of weather conditions and seasons on COVID-19 case spread The temperature and regional climate effects on communitarian COVID-19 contagion in Mexico throughout phase 1 Sanchis-Gomar F. Association between climate and new daily diagnoses of COVID-19 Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus Emergence of genomic diversity and recurrent mutations in SARS-CoV-2 A summary of the diagnostic and prognostic value of hemocytometry markers in COVID-19 patients How do routine laboratory tests change in coronavirus disease 2019? Laboratory findings of COVID-19: a systematic review and meta-analysis Hematological findings and complications of COVID-19 Laboratory findings in COVID-19 diagnosis and prognosis Estimates of the severity of coronavirus disease 2019: a model-based analysis Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19 COVID-19 and the clinical hematology laboratory NLR: a cost-effective nomogram to guide therapeutic interventions in COVID-19 Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19 Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan Association of red blood cell distribution width with mortality risk in hospitalized adults with SARS-CoV-2 infection The laboratory's role in combating COVID-19 Early Predictors of clinical deterioration in a cohort of 239 patients hospitalized for covid-19 infection in Lombardy, Italy Prognostic value of cardiovascular biomarkers in COVID-19: a review Abnormal liver function tests in patients with COVID-19: relevance and potential pathogenesis De Ritis ratio and biochemical parameters in COVID-19 patients Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study. Diabetologia Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19) Covid-19 in critically ill patients in the seattle region -case series Changes of hematological and immunological parameters in COVID-19 patients Lymphocyte-to-c-reactive protein ratio: a novel predictor of adverse outcomes in COVID-19 Hematological manifestations of CO-VID-19 Date of submission Date of decision Date of acceptance Date of web publication This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. Additional files Additional file 1: Hospital ethics approval document. Additional Table 1 : Seasonal comparison of age, gender and hematological biomarkers between the groups on admission. Additional Table 2 : Comparison of gender and hematological biomarkers between the groups on admission. Additional Table 3 : Seasonal differences in biochemical biomarkers between the groups on admission. Additional Table 4 : Differences in biochemical biomarkers between the groups on admission. Additional Table 5 : Seasonal differences in inflammatory, cardiac and coagulation biomarkers between the groups on admission. Additional Table 6 : Differences in inflammatory, cardiac and coagulation biomarkers between the groups on admission.